Crossmark

ECMO-treatment in patients with acute lung failure, cardiogenic, and septic shock: mortality and ECMO-learning curve over a 6-year period

Crossref DOI link: https://doi.org/10.1186/s40560-018-0352-2

Published Online: 2018-12-18

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Banjas, Norbert

Hopf, Hans-Bernd

Hanisch, Ernst

Friedrichson, Benjamin

Fichte, Julia

Buia, Alexander http://orcid.org/0000-0002-8090-5453
License Information

Text and Data Mining valid from 2018-12-01
More Information

Article History

Received: 27 July 2018

Accepted: 3 December 2018

First Online: 18 December 2018

Change Date: 31 January 2019

Change Type: Correction

Change Details: In the original publication of this article [1], an Author’s Note section is missing in Declaration.

Ethics approval and consent to participate

: The study was approved by the Ethics Commission of the State Medical Council of Hesse [Ethikkommission der Landesärztekammer Hessen] (file reference no. 88/2017).

: Not applicable.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.